Study Reference No. - C1D00513

Study Reference No. Study Type Compensation Gender Age Demographic
C1D00513 Healthy $2,390 Males and Females 18-50 In general good health; non-smokers for at least the past 1 year
Study Details

Study Purpose

The purpose of this study is to compare the amount of active drug in your blood after a dose of the reference product (R) tablets, compared to two sprays of the test product (T), nasal spray

Study Duration

Approx. 16 days total; 2 periods with overnight stays, 3 returns/ period

Study Schedule

General Screening


Study Visit(s)

Period Check-in(PM) Check-out(AM) 48 hr return (AM) 72 hr return (AM) 96 hr return (AM)
1 28-Jan-21 30-Jan-21 31-Jan-21 01-Feb-21 02-Feb-21
2 09-Feb-21 11-Feb-21 12-Feb-21 13-Feb-21 14-Feb-21

Follow-Up Visit(s)


Other Notes

Bring Valid Photo ID.

COVID-19 test will be conducted prior to each period check-in.